Ublituximab
TGTX 1101-101
Phase 2 small_molecule completed
Quick answer
Ublituximab for Non-Hodgkins Lymphoma is a Phase 2 program (small_molecule) at TG THERAPEUTICS, INC. with 2 ClinicalTrials.gov record(s).
Program details
- Company
- TG THERAPEUTICS, INC.
- Indication
- Non-Hodgkins Lymphoma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed